David Cragg - 09 Nov 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Chief HR & Admin Officer
Signature: By: Robert Wong For: David Cragg
Issuer symbol: CYTK
Transactions as of: 09 Nov 2021
Net transactions value: -$1,444,959
Form type: 4
Filing time: 09 Nov 2021, 16:35:14 UTC
Previous filing: 02 Nov 2021
Next filing: 17 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$236,608	+24,519	+18%	$9.65	163,223	09 Nov 2021	Direct	F1
transaction	CYTK	Common Stock	Sale	$1,023,918	-24,519	-15%	$41.76	138,704	09 Nov 2021	Direct	F1
transaction	CYTK	Common Stock	Options Exercise	$197,642	+20,481	+15%	$9.65	159,185	09 Nov 2021	Direct	F1
transaction	CYTK	Common Stock	Sale	$855,291	-20,481	-13%	$41.76	138,704	09 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Incentive Stock Option (right to buy)	Options Exercise	$0	-20,481	-100%	$0.000000^*	0	09 Nov 2021	Common Stock	20,481	$9.65	Direct
transaction	CYTK	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-24,519	-100%	$0.000000^*	0	09 Nov 2021	Common Stock	24,519	$9.65	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.